Winzenborg, I., Polepally, A. R., Nader, A., Mostafa, N. M., Noertersheuser, P., & Ng, J. (2020). Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model. CPT Pharmacometrics Syst Pharmacol.

Winzenborg, Insa, Akshanth R. Polepally, Ahmed Nader, Nael M. Mostafa, Peter Noertersheuser, and Juki Ng. "Effect of Elagolix Exposure On Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model." CPT Pharmacometrics Syst Pharmacol 2020.

Winzenborg, Insa, et al. "Effect of Elagolix Exposure On Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model." CPT Pharmacometrics Syst Pharmacol 2020.